Drugs / Chlorpromazine
last change Jul 2026 re-read 2 minutes ago

Chlorpromazine

Small molecule targets DRD2, HTR2A via inhibition

Developed for
COVID-19 · delirium · glioblastoma · ischemic stroke · psychotic disorder · schizophrenia · malignant colon neoplasm · bipolar disorder
+3 more · neonatal abstinence syndrome · schizoaffective disorder · visual impairment and progressive phthisis bulbi
Investigated by
M.D. Anderson Cancer Center · Cairo University · Cancer Prevention Research Institute of Texas · Capital Medical University · Carlo Besta Neurological Institute · Centre Hospitalier St Anne
+22 more · Commonwealth Research Center, Massachusetts · Cycle Pharmaceuticals Ltd. · Dartmouth-Hitchcock Medical Center · Fundación Pública Andaluza Progreso y Salud · Harvard Medical School (HMS and HSDM) · Hôpital Cochin · Instituto de Salud Carlos III · Ji Xunming,MD,PhD · Linyi People's Hospital · Marco G Paggi, MD, PhD · Mohammed Milhem · National Cancer Institute (NCI) · National Institute of Mental Health (NIMH) · National Institute of Nursing Research (NINR) · National Institutes of Health (NIH) · Noha Mahmoud Nasreldin Hassan · Novartis · Parexel · Regina Elena Cancer Institute · Sadat City University · University of Sao Paulo · Veneto Institute of Oncology IRCCS

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) THORAZINE 1957-09-18 fda.gov

Trials 13 · a red edge is where a trial was stopped

19561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT06663631 Nov 2024 → Jan 2025 overdue ischemic stroke Capital Medical University Recruiting No outcome recorded
Phase 1 NCT05190315 Jan 2022 → Apr 2023 glioblastoma Mohammed Milhem Completed No outcome recorded
Phase 1 NCT02943213 Nov → Dec 2016 acute intermittent porphyria, chronic hiccup, manic bipolar affective disorder, schizophrenia Cycle Pharmaceuticals Ltd. Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT05433402 Jul → Sep 2022 malignant colon neoplasm Sadat City University Withdrawn No outcome recorded
Phase 21 trial
Phase 2 NCT04224441 Dec 2019 → Jun 2022 glioblastoma Marco G Paggi, MD, PhD Unknown No outcome recorded
Phase 2/33 trials
Phase 2/3 NCT05431595 Jul 2022 → Feb 2027 expected delirium, epilepsy M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 2/3 NCT04354805 Aug → Oct 2020 COVID-19 Cairo University Unknown No outcome recorded
Phase 2/3 NCT03021486 Jun 2017 → Jun 2021 overdue delirium, metastatic malignant neoplasm M.D. Anderson Cancer Center Active not recruiting No outcome recorded
Phase 32 trials
Phase 3 NCT04366739 Apr → Aug 2020 COVID-19 Centre Hospitalier St Anne Withdrawn No outcome recorded
Phase 3 NCT01765829 Nov 2012 → Nov 2015 psychotic disorder Fundación Pública Andaluza Progreso y Salud Unknown No outcome recorded
Phase 42 trials
Phase 4 NCT01016145 Apr 2009 → Jun 2010 psychotic disorder University of Sao Paulo Unknown No outcome recorded
Phase 4 NCT00169039 Dec 1994 → Feb 2002 schizophrenia Harvard Medical School (HMS and HSDM) Terminated No outcome recorded
Phase not applicable1 trial
NCT07364344 Jan → Jul 2026 overdue ischemic stroke Ji Xunming,MD,PhD Not yet recruiting No outcome recorded
Also used as a comparator or background therapy in 8 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01323205 Background May 2011 → Nov 2012 schizophrenia Janssen Research & Development, LLC Completed No outcome recorded
Phase 32 trials
Phase 3 NCT00882518 Comparator Apr 2009 → Jul 2010 schizophrenia AstraZeneca Completed No outcome recorded
Phase 3 NCT02810782 Comparator Jun 2001 → Dec 2007 neonatal abstinence syndrome University of Zurich Completed No outcome recorded
Phase 43 trials
Phase 4 NCT03639558 Comparator Aug 2018 → Jul 2019 Joseph Dib Completed No outcome recorded
Phase 4 NCT00654576 Comparator Feb 2005 → Dec 2007 schizophrenia Central South University Completed No outcome recorded
Phase 4 NCT00202293 Comparator Oct 2001 → Nov 2015 bipolar disorder, schizoaffective disorder Melbourne Health Completed No outcome recorded
Phase not applicable2 trials
NCT03183310 Comparator Jul → Oct 2017 gastroesophageal reflux disease Universitaire Ziekenhuizen KU Leuven Unknown No outcome recorded
NCT01404364 Comparator Jan → Dec 2010 glaucoma, visual impairment and progressive phthisis bulbi Hospital Governador Celso Ramos Completed No outcome recorded

Evidence & citations 41 cited values

Every value below carries the sentence it was read from. 22 sources stand behind the page.

FieldValueCited text
Known as Chlorpromazine “Drugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine,...” NCT01765829
18

“Haloperidol 2,5-10 mg; chlorpromazine 25-600 mg.” NCT01016145

NCT00882518

NCT05431595

NCT05433402

NCT03639558

NCT06663631

NCT00169039

NCT05190315

NCT04224441

NCT07364344

NCT03021486

NCT04354805

NCT00202293

NCT03183310

NCT04366739

NCT01404364

NCT00654576

NCT02810782

Known as Aminazine ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Chloractil ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Chlorpromazine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Chlorpromazine Hydrochloride “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205
1

NCT02943213

Known as Chlorpromazine hydrochloride intensol ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Chlorpromazine hydrochloride, Thorazine Chlorpromazine hydrochloride, Thorazine®” NCT05431595
Known as Chlorpromazini hydrochloridum ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Chlorpromazinum ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Clorpromazina ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as CPZ “Chlorpromazine (CPZ, Largactil, Thorazine) is a potent antagonist of the dopamine receptor D2 (DRD2) and has been effectively and safely employed for over half a century in the...” NCT04224441
1

“CHLORPROMAZINE (CPZ)” NCT04366739

Known as Elmarin ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Esmind ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Fenactil ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as J2.794D ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Klorproman ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Largactil “Chlorpromazine (CPZ, Largactil, Thorazine) is a potent antagonist of the dopamine receptor D2 (DRD2) and has been effectively and safely employed for over half a century in the...” NCT04224441
1

“The effect of chlorpromazine (Largactil) on esophageal sensitivity will be investigated in this study.” NCT03183310

Known as Largactil fte ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Largactilothiazine ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Marazine ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Megaphen ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Nci-c05210 ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Norcozine ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as Novomazina ChEMBL registry synonym — accepted as the source's own label CHEMBL71
Known as NSC-167745 ChEMBL registry synonym — accepted as the source's own label CHEMBL71